在慢性呼吸道疾病中,HSP70陪伴者IL-33
bioRxiv : the preprint server for biology
|February 20, 2025
概括
热冲击蛋白70 (HSP70) 促进了干白素-33 (IL-33) 的分泌和稳定,这是气道炎症的关键驱动因素. 针对这种相互作用可能为慢性呼吸道疾病提供新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 干白素-33 (IL-33) 在呼吸道上皮细胞生物学中驱动2型炎症.
- 慢性呼吸道疾病中IL-33分泌和调节的机制尚不清楚.
研究的目的:
- 定义与疾病相关的异型IL-33d34是如何被招募到非正规分泌途径的.
- 研究热冲击蛋白70 (HSP70) 在IL-33d34分泌中的作用.
主要方法:
- 评估IL-33d34与HSP70的相互作用,使用亲和力净化,质谱和近距离标记.
- 使用分泌和活性报告测试来研究HSP70对IL-33d34分泌和受体结合的影响.
- 分析了人类呼吸道疾病生物标本,以检测热冲击路径失调.
主要成果:
- 证实了HSP70和IL-33d34之间的直接相互作用,将其招募到囊泡中并增强分泌稳定性.
- 在气道疾病样本和细胞外囊泡中观察到IL-33,HSP70和蛋白质稳定介质的失调.
- 描述了IL-33d34相互作用体的特征,并确定了新的分泌调节剂.
结论:
- HSP70在非正规IL-33d34的分泌和功能中起作用.
- 这种HSP70-IL-33d34相互作用为呼吸道疾病提供了潜在的治疗点.
相关概念视频
T Cell Types and Functions
897
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
897
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
339
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
339
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
343
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
343


